Founded in 2020 and headquartered in Boca Raton, Florida, Vapocoolshot is dedicated to developing and manufacturing innovative technology aimed at reducing pain and anxiety. Their core mission is to alleviate the discomfort associated with medical procedures, particularly for individuals with a clinical fear of needles. Vapocoolshot's flagship product, CoolJect, is a fast-acting topical anesthetic widely used by healthcare providers across various specialties, including hand surgery, podiatry, orthopedics, dermatology, pediatrics, and urgent care.
Vapocoolshot has garnered attention from notable healthcare professionals and investors for its impactful contributions to pain management. The company's achievements include widespread adoption of CoolJect in diverse medical settings and positive feedback from both patients and healthcare providers. By focusing on reducing procedural pain and anxiety, Vapocoolshot has significantly improved patient experiences and outcomes, positioning itself as a key player in the medical technology industry.
